Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Earnings
CrossFirst Bancshares reports Q3 EPS 41c, consensus 30c » 18:46
10/18/21
10/18
18:46
10/18/21
18:46
CFB

CrossFirst Bancshares

$13.66 /

+0.02 (+0.15%)

Reports Q3 operating…

Reports Q3 operating revenue $40.7M, consensus $46.5M. "We had another quarter of strong profitability and have continued our strong earnings momentum as the economy accelerates and credit quality improves from last year's low points," said CrossFirst's CEO and President, Mike Maddox. "We continue to take a long-term view that will best serve our constituents well into the future by investing in talent to grow our top-line revenue and by investing in technology to better serve our clients. At the same time, we remain committed to delivering value to our shareholders and are pleased to be able to continue the return of capital with the new buyback program."

ShowHide Related Items >><<
CFB CrossFirst Bancshares
$13.66 /

+0.02 (+0.15%)

CFB CrossFirst Bancshares
$13.66 /

+0.02 (+0.15%)

03/08/21 Truist
CrossFirst Bancshares price target raised to $15 from $12 at Truist
12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
CFB CrossFirst Bancshares
$13.66 /

+0.02 (+0.15%)

CFB CrossFirst Bancshares
$13.66 /

+0.02 (+0.15%)

Over a quarter ago
Earnings
CrossFirst Bancshares reports Q2 EPS 30c, consensus 26c » 16:07
07/22/21
07/22
16:07
07/22/21
16:07
CFB

CrossFirst Bancshares

$13.77 /

-0.05 (-0.36%)

The Company produced…

The Company produced interest income of $48.5M for the second quarter of 2021, a decrease of 5% from the second quarter of 2020 and a slight increase from the previous quarter. Interest income was down from the second quarter of 2020 primarily due to the impact of lower market interest rates and increased competition for loans, which led to lower loan and bond yields. Average earning assets totaled $5.5 billion for the second quarter of 2021, an increase of $264 million or 5% from the same quarter in 2020. The tax-equivalent yield on earning assets increased from 3.50% to 3.57% during the second quarter of 2021, and was down from 3.96% recorded in the second quarter of 2020, primarily due to the movement . "During the second quarter, we achieved the strongest profitability in the Company's history and I am extremely proud of our team for executing on several key strategic initiatives that provides a foundation for future growth and success," said CrossFirst's CEO and President, Mike Maddox. "The Company took several steps to improve the efficiency of the balance sheet and reduce excess liquidity, which resulted in stronger performance metrics, improved margin, and stronger core earnings power. We grew our operating revenue 6% from the previous quarter and our asset quality metrics improved with the strengthening of the loan portfolio and economic recovery. We made great progress on our expansion efforts in Arizona and Frisco, which we believe will create long term value for the organization." Reports book value per share of $12.50 at June 30 compared to $11.66 at June 30, 2020

ShowHide Related Items >><<
CFB CrossFirst Bancshares
$13.77 /

-0.05 (-0.36%)

CFB CrossFirst Bancshares
$13.77 /

-0.05 (-0.36%)

03/08/21 Truist
CrossFirst Bancshares price target raised to $15 from $12 at Truist
12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
CFB CrossFirst Bancshares
$13.77 /

-0.05 (-0.36%)

CFB CrossFirst Bancshares
$13.77 /

-0.05 (-0.36%)

Hot Stocks
CrossFirst Bankshares names Ben Clouse CFO » 16:08
06/21/21
06/21
16:08
06/21/21
16:08
CFB

CrossFirst Bancshares

$15.00 /

+0.11 (+0.74%)

, WDR

Waddell & Reed

$24.99 /

+ (+0.00%)

CrossFirst Bankshares…

CrossFirst Bankshares (CFB) announced that it has named Ben Clouse as Chief Financial Officer. In the CFO role, Clouse will lead the financial organization and be responsible for overall long-range financial planning and reporting as well as support execution of the bank's growth strategy. "After conducting a thorough nationwide search, we are pleased to have found the ideal CFO candidate right here in Kansas City," said President & CEO of CrossFirst Mike Maddox. "Ben has deep and extensive experience in leading financial operations as well as driving operational change, including as the Chief Financial Officer of a publicly-traded company. He will be a key part of our executive leadership team and I know will be instrumental in helping us to continue to grow strategically as well as meet the evolving and changing needs of our clients." Prior to joining CrossFirst, Clouse was CFO of Waddell & Reed (WDR).

ShowHide Related Items >><<
WDR Waddell & Reed
$24.99 /

+ (+0.00%)

CFB CrossFirst Bancshares
$15.00 /

+0.11 (+0.74%)

CFB CrossFirst Bancshares
$15.00 /

+0.11 (+0.74%)

03/08/21 Truist
CrossFirst Bancshares price target raised to $15 from $12 at Truist
12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
07/20/20 Truist
CrossFirst Bancshares initiated with a Hold at SunTrust
WDR Waddell & Reed
$24.99 /

+ (+0.00%)

12/04/20 Morgan Stanley
Morgan Stanley upgrades Waddell & Reed to Equal Weight, assumes deal will close
12/04/20 Morgan Stanley
Waddell & Reed upgraded to Equal Weight from Underweight at Morgan Stanley
12/03/20 Evercore ISI
Waddell & Reed upgraded to In Line from Underperform at Evercore ISI
10/05/20 Jefferies
Trian involvement could by catalyst for 'beaten down' managers, says Jefferies
WDR Waddell & Reed
$24.99 /

+ (+0.00%)

CFB CrossFirst Bancshares
$15.00 /

+0.11 (+0.74%)

WDR Waddell & Reed
$24.99 /

+ (+0.00%)

CFB CrossFirst Bancshares
$15.00 /

+0.11 (+0.74%)

Hot Stocks
CrossFirst Bancshares enters Phoenix market » 16:08
06/14/21
06/14
16:08
06/14/21
16:08
CFB

CrossFirst Bancshares

$14.53 /

+0.025 (+0.17%)

CrossFirst Bankshares…

CrossFirst Bankshares announced that it has plans to enter the Phoenix, Arizona market and has named Kevin Halloran as Phoenix Market President. "As we looked to expand outside our traditional CrossFirst footprint, we believe Phoenix is a great opportunity given the region's favorable demographics, strong population, and business growth," said President & CEO of CrossFirst Bankshares, Inc., Mike Maddox. "As an entrepreneurial bank, we are excited about the opportunity to work with businesses and professionals in Phoenix and Maricopa County and to support the region's rapid growth. We are fortunate to have identified a local leader in Kevin Halloran, who brings decades of banking and financial services experience as well as deep Arizona connections to the role."

ShowHide Related Items >><<
CFB CrossFirst Bancshares
$14.53 /

+0.025 (+0.17%)

CFB CrossFirst Bancshares
$14.53 /

+0.025 (+0.17%)

03/08/21 Truist
CrossFirst Bancshares price target raised to $15 from $12 at Truist
12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
07/20/20 Truist
CrossFirst Bancshares initiated with a Hold at SunTrust
CFB CrossFirst Bancshares
$14.53 /

+0.025 (+0.17%)

CFB CrossFirst Bancshares
$14.53 /

+0.025 (+0.17%)

Earnings
CrossFirst Bancshares reports Q1 EPS23c, consensus 19c » 16:17
04/22/21
04/22
16:17
04/22/21
16:17
CFB

CrossFirst Bancshares

$13.43 /

+0.03 (+0.22%)

Reports Q1 revenue…

Reports Q1 revenue $40.3M, consensus $43.81M."I am extremely proud of our team's effort as we posted our highest quarterly net income to date for the first quarter, despite still having elevated provisioning and additional margin compression from persistently low interest rates," said CrossFirst's CEO and President Mike Maddox. "The Company's performance was impacted by continued organic growth and enhanced by the efficiency initiatives we implemented in 2020, which contributed to generating positive operating revenue growth and our highest quarterly pre-tax, pre-provision profits to date for the first quarter. Our asset quality and related metrics continued to trend in the right direction as a result of the economic recovery, additional fiscal stimulus, regulatory relief, and stronger energy prices." The Company produced interest income of $48.2 million for the first quarter of 2021, a decrease of 11% from the first quarter of 2020 and a decrease of 3% from the previous quarter. Interest income was down from the first quarter of 2020 primarily due to the impact of lower market interest rates and increased competition for loans, which led to lower loan and bond yields. Average earning assets totaled $5.7 billion for the first quarter of 2021, an increase of $829 million or 17% from the same quarter in 2020. The tax-equivalent yield on earning assets declined from 3.71% to 3.50% during the first quarter of 2021, and was down from 4.57% recorded in the first quarter of 2020, primarily due to the movement of variable rate assets indexed to lower market rates.

ShowHide Related Items >><<
CFB CrossFirst Bancshares
$13.43 /

+0.03 (+0.22%)

CFB CrossFirst Bancshares
$13.43 /

+0.03 (+0.22%)

03/08/21 Truist
CrossFirst Bancshares price target raised to $15 from $12 at Truist
12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
07/20/20 Truist
CrossFirst Bancshares initiated with a Hold at SunTrust
CFB CrossFirst Bancshares
$13.43 /

+0.03 (+0.22%)

CFB CrossFirst Bancshares
$13.43 /

+0.03 (+0.22%)

Options
new option listings and three option delistings on April 21st » 08:30
04/21/21
04/21
08:30
04/21/21
08:30
APP

AppLovin

$60.40 /

+1.71 (+2.91%)

, BSPE

Bespoke Capital Acquisition

$10.08 /

+0.09 (+0.90%)

, CFB

CrossFirst Bancshares

$13.38 /

-0.27 (-1.98%)

, CHRA

Charah Solutions

$5.67 /

-0.47 (-7.65%)

, CTEC

Cholestech

$19.97 /

-0.63 (-3.06%)

, CYCC

Cyclacel Pharmaceuticals

$6.40 /

-0.11 (-1.69%)

, DFNS

LGL Systems Acquisition

$9.90 /

-0.04 (-0.40%)

, FARM

Farmer Bros.

$9.98 /

-0.29 (-2.82%)

, FSTX

F-star Therapeutics

$9.48 /

-0.28 (-2.87%)

, GENI

Genius Sports

$16.23 /

-2.025 (-11.09%)

, GNPK

Genesis Park Acquisition

$10.13 /

-0.06 (-0.59%)

, IDEV

Indevus

$66.33 /

-1.07 (-1.59%)

, INFU

InfuSystem

$21.63 /

-0.17 (-0.78%)

, JOAN

Joann

$11.37 /

-0.02 (-0.18%)

, MAX

MediaAlpha

$32.98 /

-1.76 (-5.07%)

, NVVE

Nuvve Holding

$8.59 /

-0.47 (-5.19%)

, OBLG

Oblong

$4.14 /

-0.19 (-4.39%)

, PSI

PSI Technologies Holdings, Inc.

$119.80 /

-2 (-1.64%)

, SCPH

scPharmaceuticals

$6.28 /

-0.13 (-2.03%)

, SMIN

Southern Mineral Corp

$45.90 /

-0.545 (-1.17%)

, SNSR

Control Devices

$33.59 /

-0.7 (-2.04%)

, WKEY

WISeKey

$8.45 /

-0.28 (-3.21%)

, XFOR

X4 Pharmaceuticals

$9.00 /

-0.3 (-3.23%)

, ZKIN

ZK International Group

$5.32 /

-0.19 (-3.45%)

, CBPO

China Biologic

$119.98 /

+2.2 (+1.87%)

, DMYD

dMY Technology II

/

+

, IPHI

Inphi

$172.33 /

-1.85 (-1.06%)

New option listings for…

New option listings for April 21st include First Trust RBA American Industrial Renaissance (AIRR), Applovin Corporation (Class A Stock) (APP), Bespoke Capital Acquisition Corporation (Class A Stock) (BSPE), CrossFirst Bankshares Inc (CFB), Charah Solutions Inc (CHRA), Global X CleanTech ETF (CTEC), Cyclacel Pharmaceuticals (CYCC), LGL Systems Acquisition Corp (Class A Stock) (DFNS), iShares Emerging Markets Dividend (DVYE), iShares MSCI Emerging Markets Asia (EEMA), Farmer Bros. (FARM), F star Therapeutics Inc (FSTX), First Trust Nasdaq Oil and Gas (FTXN), First Trust Nasdaq Bank (FTXO), First Trust Nasdaq Transportation (FTXR), First Trust Small Cap Core AlphaDEX Fund (FYX), Genius Sports Limited (GENI), Genesis Park Acquisition Corp (Class A Stock) (GNPK), iShares Core MSCI International Developed Markets ETF (IDEV), InfuSystem (INFU), iShares Russell Top 200 Growth (IWY), iShares US Consumer Services (IYC), iShares US Consumer Goods (IYK), JOANN Inc (JOAN), MediaAlpha Inc (Class A Stock) (MAX), Nuvve Holding Corporation (NVVE), Oblong Inc (OBLG), PowerShares Dynamic Semiconductors Portfolio (PSI), scPharmaceuticals Inc (SCPH), iShares MSCI India Small Cap ETF (SMIN), Global X Internet of Things Thematic (SNSR), Soaring Eagle Acquisition Corporation (Units) (SRNGU), iShares Core US REIT ETF (USRT), Vanguard International Dividend Appreciation ETN (VIGI), WISeKey International Holdings SA (ADR) (WKEY), X4 Pharmaceuticals Inc (XFOR), and ZK International Group Co Ltd (ZKIN). Option delistings effective April 21st include China Bioligic Products Holdings Inc (CBPO), dMY Technology Group Inc II (Class A Stock) (DMYD), and Inphi Corporation (IPHI).

ShowHide Related Items >><<
ZKIN ZK International Group
$5.32 /

-0.19 (-3.45%)

XFOR X4 Pharmaceuticals
$9.00 /

-0.3 (-3.23%)

WKEY WISeKey
$8.45 /

-0.28 (-3.21%)

SCPH scPharmaceuticals
$6.28 /

-0.13 (-2.03%)

OBLG Oblong
$4.14 /

-0.19 (-4.39%)

MAX MediaAlpha
$32.98 /

-1.76 (-5.07%)

JOAN Joann
$11.37 /

-0.02 (-0.18%)

IPHI Inphi
$172.33 /

-1.85 (-1.06%)

INFU InfuSystem
$21.63 /

-0.17 (-0.78%)

FSTX F-star Therapeutics
$9.48 /

-0.28 (-2.87%)

FARM Farmer Bros.
$9.98 /

-0.29 (-2.82%)

DMYD dMY Technology II
/

+

DFNS LGL Systems Acquisition
$9.90 /

-0.04 (-0.40%)

CYCC Cyclacel Pharmaceuticals
$6.40 /

-0.11 (-1.69%)

CHRA Charah Solutions
$5.67 /

-0.47 (-7.65%)

CFB CrossFirst Bancshares
$13.38 /

-0.27 (-1.98%)

CBPO China Biologic
$119.98 /

+2.2 (+1.87%)

APP AppLovin
$60.40 /

+1.71 (+2.91%)

BSPE Bespoke Capital Acquisition
$10.08 /

+0.09 (+0.90%)

04/21/21 Telsey Advisory
Bespoke Capital Acquisition initiated with an Outperform at Telsey Advisory
04/21/21 Telsey Advisory
Bespoke Capital Acquisition initiated with an Outperform at Telsey Advisory
CFB CrossFirst Bancshares
$13.38 /

-0.27 (-1.98%)

03/08/21 Truist
CrossFirst Bancshares price target raised to $15 from $12 at Truist
12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
07/20/20 Truist
CrossFirst Bancshares initiated with a Hold at SunTrust
CHRA Charah Solutions
$5.67 /

-0.47 (-7.65%)

CTEC Cholestech
$19.97 /

-0.63 (-3.06%)

CYCC Cyclacel Pharmaceuticals
$6.40 /

-0.11 (-1.69%)

05/19/20 Brookline
Cyclacel Pharmaceuticals initiated with a Buy at Brookline
04/27/20
Fly Intel: Top five analyst initiations
04/27/20 Roth Capital
Cyclacel Pharmaceuticals assumed with a Buy at Roth Capital
DFNS LGL Systems Acquisition
$9.90 /

-0.04 (-0.40%)

FARM Farmer Bros.
$9.98 /

-0.29 (-2.82%)

03/31/21 B. Riley
B. Riley upgrades Farmer Bros. to Buy with recovery 'turning a corner'
03/31/21 B. Riley
Farmer Bros. upgraded to Buy from Neutral at B. Riley Securities
02/08/21 Roth Capital
Farmer Bros. price target raised to $7 from $6 at Roth Capital
01/08/21 B. Riley
Farmer Bros. price target raised to $4.50 from $4 at B. Riley Securities
FSTX F-star Therapeutics
$9.48 /

-0.28 (-2.87%)

04/15/21 Oppenheimer
Opco starts F-star Therapeutics with Outperform, $30 price target
04/15/21 Oppenheimer
F-star Therapeutics initiated with an Outperform at Oppenheimer
04/08/21 William Blair
F-star Therapeutics initiated with an Outperform at William Blair
03/24/21
Fly Intel: Top five analyst initiations
GENI Genius Sports
$16.23 /

-2.025 (-11.09%)

02/23/21 Benchmark
dMY Technology II initiated with a Buy at Benchmark
GNPK Genesis Park Acquisition
$10.13 /

-0.06 (-0.59%)

IDEV Indevus
$66.33 /

-1.07 (-1.59%)

INFU InfuSystem
$21.63 /

-0.17 (-0.78%)

12/29/20 Sidoti
InfuSystem initiated with a Buy at Sidoti
08/31/20
Fly Intel: Top five analyst initiations
08/31/20 Craig-Hallum
InfuSystem initiated with a Buy at Craig-Hallum
06/09/20 Lake Street
InfuSystem initiated with a Buy at Lake Street
JOAN Joann
$11.37 /

-0.02 (-0.18%)

04/06/21 William Blair
Joann initiated with an Outperform at William Blair
04/06/21 BofA
BofA starts Joann at Buy with $27 price target
04/06/21 Wells Fargo
Joann initiated with an Overweight at Wells Fargo
04/06/21 Guggenheim
Joann initiated with a Buy at Guggenheim
MAX MediaAlpha
$32.98 /

-1.76 (-5.07%)

03/12/21 Canaccord
MediaAlpha price target raised to $75 from $54 at Canaccord
03/12/21 RBC Capital
MediaAlpha price target raised to $65 from $50 at RBC Capital
12/11/20 Canaccord
MediaAlpha expected to be part of any insurance marketing, says Canaccord
12/08/20
Fly Intel: Top five analyst initiations
NVVE Nuvve Holding
$8.59 /

-0.47 (-5.19%)

04/19/21 Craig-Hallum
Nuvve Holding initiated with a Buy at Craig-Hallum
OBLG Oblong
$4.14 /

-0.19 (-4.39%)

PSI PSI Technologies Holdings, Inc.
$119.80 /

-2 (-1.64%)

SCPH scPharmaceuticals
$6.28 /

-0.13 (-2.03%)

12/08/20 BMO Capital
scPharmaceuticals price target lowered to $10 from $13 at BMO Capital
05/13/20 SVB Leerink
scPharmaceuticals price target raised to $12 from $7 at SVB Leerink
05/13/20 H.C. Wainwright
scPharmaceuticals price target raised to $15 from $13 at H.C. Wainwright
SMIN Southern Mineral Corp
$45.90 /

-0.545 (-1.17%)

SNSR Control Devices
$33.59 /

-0.7 (-2.04%)

WKEY WISeKey
$8.45 /

-0.28 (-3.21%)

09/09/20 H.C. Wainwright
WISeKey price target raised to $9 from $6 at H.C. Wainwright
XFOR X4 Pharmaceuticals
$9.00 /

-0.3 (-3.23%)

12/17/20 Brookline
X4 Pharmaceuticals initiated with a Buy at Brookline
12/14/20 Roth Capital
New CMO 'another solid addition' to X4 Pharmaceuticals team, says Roth Capital
06/12/20 Roth Capital
X4 Pharmaceuticals data boost confidence in Phase 3 study, says Roth Capital
ZKIN ZK International Group
$5.32 /

-0.19 (-3.45%)

CBPO China Biologic
$119.98 /

+2.2 (+1.87%)

DMYD dMY Technology II
/

+

04/07/21 Craig-Hallum
Craig-Hallum sees Genius as 'a clear winner' after NY online sports betting news
04/05/21 Craig-Hallum
Genius Sports price target raised to $30 from $25 at Craig-Hallum
02/25/21 B. Riley
B. Riley starts dMY at Buy as better way to invest in sports betting
02/24/21 B. Riley
dMY Technology II initiated with a Buy at B. Riley Securities
IPHI Inphi
$172.33 /

-1.85 (-1.06%)

03/24/21 Stifel
Chinese approval for Inphi deal 'highly favorable' for Marvell, says Stifel
02/16/21 Needham
Inphi price target raised to $191 from $175 at Needham
02/09/21 Barclays
Inphi downgraded to Equal Weight on Marvell deal at Barclays
02/09/21 Barclays
Inphi downgraded to Equal Weight from Overweight at Barclays
XFOR X4 Pharmaceuticals
$9.00 /

-0.3 (-3.23%)

SCPH scPharmaceuticals
$6.28 /

-0.13 (-2.03%)

MAX MediaAlpha
$32.98 /

-1.76 (-5.07%)

JOAN Joann
$11.37 /

-0.02 (-0.18%)

IPHI Inphi
$172.33 /

-1.85 (-1.06%)

INFU InfuSystem
$21.63 /

-0.17 (-0.78%)

FSTX F-star Therapeutics
$9.48 /

-0.28 (-2.87%)

FARM Farmer Bros.
$9.98 /

-0.29 (-2.82%)

CYCC Cyclacel Pharmaceuticals
$6.40 /

-0.11 (-1.69%)

CFB CrossFirst Bancshares
$13.38 /

-0.27 (-1.98%)

CBPO China Biologic
$119.98 /

+2.2 (+1.87%)

  • 15
    Apr
  • 19
    Mar
  • 12
    Mar
  • 12
    Mar
  • 28
    Oct
  • 21
    May
IPHI Inphi
$172.33 /

-1.85 (-1.06%)

DMYD dMY Technology II
/

+

MAX MediaAlpha
$32.98 /

-1.76 (-5.07%)

JOAN Joann
$11.37 /

-0.02 (-0.18%)

IPHI Inphi
$172.33 /

-1.85 (-1.06%)

GNPK Genesis Park Acquisition
$10.13 /

-0.06 (-0.59%)

GENI Genius Sports
$16.23 /

-2.025 (-11.09%)

FARM Farmer Bros.
$9.98 /

-0.29 (-2.82%)

DMYD dMY Technology II
/

+

DFNS LGL Systems Acquisition
$9.90 /

-0.04 (-0.40%)

APP AppLovin
$60.40 /

+1.71 (+2.91%)

DMYD dMY Technology II
/

+

Hot Stocks
CrossFirst Bancshares announces CFO David O'Toole retiring » 09:22
03/15/21
03/15
09:22
03/15/21
09:22
CFB

CrossFirst Bancshares

$15.11 /

+0.1 (+0.67%)

CrossFirst Bankshares…

CrossFirst Bankshares announced that David L. O'Toole, Chief Financial Officer, Chief Investment Officer and a founding shareholder/board member, has announced his plan to retire from CrossFirst after nearly 15 years of service. Mr. O'Toole has served in his current roles for his entire time with the Company.

ShowHide Related Items >><<
CFB CrossFirst Bancshares
$15.11 /

+0.1 (+0.67%)

CFB CrossFirst Bancshares
$15.11 /

+0.1 (+0.67%)

03/08/21 Truist
CrossFirst Bancshares price target raised to $15 from $12 at Truist
12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
07/20/20 Truist
CrossFirst Bancshares initiated with a Hold at SunTrust
CFB CrossFirst Bancshares
$15.11 /

+0.1 (+0.67%)

Hot Stocks
CrossFirst Bancshares announces CFO David O'Toole retiring » 09:22
03/15/21
03/15
09:22
03/15/21
09:22
CFB

CrossFirst Bancshares

$15.11 /

+0.1 (+0.67%)

CrossFirst Bankshares…

CrossFirst Bankshares announced that David L. O'Toole, Chief Financial Officer, Chief Investment Officer and a founding shareholder/board member, has announced his plan to retire from CrossFirst after nearly 15 years of service. Mr. O'Toole has served in his current roles for his entire time with the Company.

ShowHide Related Items >><<
CFB CrossFirst Bancshares
$15.11 /

+0.1 (+0.67%)

CFB CrossFirst Bancshares
$15.11 /

+0.1 (+0.67%)

03/08/21 Truist
CrossFirst Bancshares price target raised to $15 from $12 at Truist
12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
07/20/20 Truist
CrossFirst Bancshares initiated with a Hold at SunTrust
CFB CrossFirst Bancshares
$15.11 /

+0.1 (+0.67%)

Recommendations
CrossFirst Bancshares price target raised to $15 from $12 at Truist » 09:16
03/08/21
03/08
09:16
03/08/21
09:16
CFB

CrossFirst Bancshares

$14.31 /

+0.54 (+3.92%)

Truist analyst Jennifer…

Truist analyst Jennifer Demba raised the firm's price target on CrossFirst Bancshares to $15 from $12 and keeps a Hold rating on the shares as part of a broader research note on Regional and Community Banks. The analyst states that the banks' near term revenue trends are challenging with constrained spread income growth over the near term, but this could improve as COVID vaccine distribution broadens. Demba adds that the demand for multifamily and industrial commercial real estate loans is "actually healthy" and could improve further in the second half of the year.

ShowHide Related Items >><<
CFB CrossFirst Bancshares
$14.31 /

+0.54 (+3.92%)

CFB CrossFirst Bancshares
$14.31 /

+0.54 (+3.92%)

12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
07/20/20 Truist
CrossFirst Bancshares initiated with a Hold at SunTrust
CFB CrossFirst Bancshares
$14.31 /

+0.54 (+3.92%)

Hot Stocks
CrossFirst Bank names Jana Merfen CTO » 15:01
02/24/21
02/24
15:01
02/24/21
15:01
CFB

CrossFirst Bancshares

$12.91 /

+0.025 (+0.19%)

CrossFirst Bank, the…

CrossFirst Bank, the primary subsidiary of CrossFirst Bankshares, announced Jana Merfen as its new Chief Technology Officer reporting to Mike Maddox, President & CEO, CrossFirst Bankshares, Inc. and CrossFirst Bank. Merfen previously served as the Chief Information Officer for Dickinson Financial Corporation for nearly four years. "I am thrilled to welcome Jana to our team," Maddox said. "Jana is an impressive leader on the forefront of technology in the financial services industry. Her strategic expertise, as well as her commendable track record in driving operational excellence and innovation, will undoubtedly further our ability to provide extraordinary service for our clients."

ShowHide Related Items >><<
CFB CrossFirst Bancshares
$12.91 /

+0.025 (+0.19%)

CFB CrossFirst Bancshares
$12.91 /

+0.025 (+0.19%)

12/07/20 Raymond James
CrossFirst Bancshares upgraded to Outperform from Market Perform at Raymond James
12/07/20 Raymond James
CrossFirst upgraded to Outperform from Market Perform at Raymond James
07/20/20 Truist
CrossFirst Bancshares initiated with a Hold at SunTrust
CFB CrossFirst Bancshares
$12.91 /

+0.025 (+0.19%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.